Trial intelligence / Profile preview

TBS-2 for Acquired Female Orgasmic Disorder

NCT01607658Phase 2Completed

Sponsor
Acerus Pharmaceuticals
Start
May 2012
Primary completion
May 2014
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of testosterone in female orgasmic disorder (FOD), sponsored by Acerus Pharmaceuticals. Started May 2012; status: completed.

02

Drugs

testosterone
03

Conditions

female orgasmic disorder (FOD)

Beyond the preview

Go deeper on NCT01607658.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01607658.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call